Premature ovarian failure and its consequences: Vasomotor symptoms, sexuality, and fertility

Journal of Clinical Oncology

Volumn 26, Issue 5, 2008, Pages 753-758

  Schover, Leslie R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; BREMELANOTIDE; ESTROGEN; GABAPENTIN; GESTAGEN; ISOFLAVONE DERIVATIVE; LUBRICATING AGENT; MELANOCORTIN RECEPTOR; PAROXETINE; PHYTOESTROGEN; PLACEBO; TAMOXIFEN; TAXANE DERIVATIVE; TESTOSTERONE; UNCLASSIFIED DRUG; VENLAFAXINE;

BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CLINICAL TRIAL; DISTRESS SYNDROME; FEMALE INFERTILITY; FEMALE SEXUAL DYSFUNCTION; HOT FLUSH; HUMAN; MENOPAUSE; NIGHT SWEAT; OVARY; PARENTHOOD; PREGNANCY; PREMATURE OVARIAN FAILURE; PREMENOPAUSE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK; SEXUAL COUNSELING; SEXUAL FUNCTION; STRESS MANAGEMENT; SYSTEMIC THERAPY; VAGINAL DRYNESS; ADRENERGIC SYSTEM; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EARLY MENOPAUSE; FEMALE; INCIDENCE; PHYSIOLOGY; PSYCHOSEXUAL DISORDER; SEXUAL DYSFUNCTION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HOT FLASHES; HUMANS; INCIDENCE; INFERTILITY, FEMALE; MENOPAUSE, PREMATURE; OVARIAN FAILURE, PREMATURE; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; VASOMOTOR SYSTEM;

EID: 39149131745     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.14.1655     Document Type: Review

References (69)

1. Bordeleau L, Pritchard K, Goodwin P, et al: Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review. Clin Ther 29:230-241, 2007
2. Partridge A, Gelber S, Gelber RD, et al: Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and VI. Eur J Cancer 43:1646-1653, 2007
3. Gupta P, Sturdee DW, Palin SL, et al: Menopausal symptoms in women treated for breast cancer: The prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9:49-58, 2006
4. Biglia N, Cozzarella M, Cacciari F, et al: Menopause after breast cancer: A survey on breast cancer survivors. Maturitas 45:29-38, 2003
5. Ganz PA, Greendale GA, Petersen L, et al: Breast cancer in younger women: Reproductive and late health effects of treatment. J Clin Oncol 21:4184-4193, 2003
6. Avis NE, Crawford S, Manuel J: Psychosocial problems among younger women with breast cancer. Psychooncology 13:295-308, 2004
7. Partridge AH, Gelber S, Peppercorn J, et al: Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22:4174-4183, 2004
8. Duffy CM, Allen SM, Clark MA: Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy. J Clin Oncol 23:766-773, 2005
9. Thewes B, Meiser B, Taylor A, et al: Fertility-and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol 23:5155-5165, 2005
10. Schover LR: Reproductive issues, in Singletary SE, Robb GL, Hortobagyi GN (eds): Advanced Therapy of Breast Disease (ed 2), Hamilton, Ontario, Canada, BC Decker Inc, 2004, pp 790-798
11. Baucom DH, Porter LS, Kirby JS, et al: Psychosocial issues confronting young women with breast cancer. Breast Dis 23:103-113, 2005
12. Lutchman Singh K, Muttukrishna S, Stein RC, et al: Predictors of ovarian reserve in young women with breast cancer. Br J Cancer 96:1806-1816, 2007
13. Jensen A, Sharif H, Svare EI, et al: Risk of breast cancer after exposure to fertility drugs: Results from a Danish cohort study. Cancer Epidemiol Biomarkers Prev 16:1400-1407, 2007
14. Lerner-Geva L, Keinan-Boker L, Blumstein T, et al: Infertility, ovulation induction treatments and the incidence of breast cancer - a historical prospective cohort of Israeli women. Breast Cancer Res Treat 100:201-212, 2006
15. Gauthier E, Paoletti X, Clavel-Chapelon F; E3N Group: Breast cancer risk associated with being treated for infertility: Results from the French E3N cohort study. Hum Reprod 19:2216-2221, 2004
16. Burkman RT, Tang MT, Malone KE, et al: Infertility drugs and the risk of breast cancer: Findings from the Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril 79:844-851, 2003
17. Terry KL, Willett WC, Rich-Edwards JW, et al: A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med 166:2484-2489, 2006
18. Anderson RA, Themmen APN, Al-Qahtani A, et al: The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod 21:2583-2592, 2006
19. Petrek NA, Naughton MJ, Case LD, et al: Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study. J Clin Oncol 24:1045-1051, 2006
20. Tham YL, Sexton K, Weiss H, et al: The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 30:126-132, 2007
21. Gerber B, Dieterich M, Müller H, et al: Controversies in preservation of ovary function and fertility in patients with breast cancer. Breast Cancer Res Treat 10.1007/s10549-007-9572-1 [epub ahead of print on April 25, 2007]
22. Oktay K, Oktem O, Reh A, et al: Letter to the Editor: Measuring the impact of chemotherapy on fertility in women with breast cancer. J Clin Oncol 24:4044-4046, 2006
23. Giuseppe L, Attilio G, Edoardo DN, et al: Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology 12:141-147, 2007
24. Bowen S, Norian J, Santoro N, et al: Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR. Fertil Steril 88:390-305, 2007
25. Bardwell WA, Profant J, Casden DR, et al: The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology 10.1002/pon.1192 [epub ahead of print on April 11, 2007]
26. Leining MG, Gelber S, Rosenberg R, et al: Menopausal-type symptoms in young breast cancer survivors. Ann Oncol 17:1777-1782, 2006
27. Nystedt M, Berglund G, Bolund C, et al: Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: A prospective randomized study. J Clin Oncol 21:1836-1844, 2003
28. Fallowfield LJ, Bliss JM, Porter LS, et al: Quality of life in the Intergroup Exemestane Study: A randomized trial of exemestane versus continued tamoxifen after 2 to 3 years of tamoxifen in postmenopausal women with primary breast cancer. J Clin Oncol 24:910-917, 2006
29. Morales L, Neven P, Timmerman D, et al: Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. Anticancer Drugs 15:753-760, 2004
30. Whelan TJ, Goss PE, Ingle JN, et al: Assessment of quality of life in MA. 17: A randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol 23:6931-6940, 2005
31. Freeman EW, Sammel MD, Lini H, et al: The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 12:258-266, 2005
32. Gold EB, Sternfeld B, Kelsey JL, et al: Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 152:463-473, 2000
33. Joffe H, Soares CN, Petrillo LF, et al: Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine. J Clin Psychiatry 68:943-950, 2007
34. Thase ME, Shelton RC, Khan A: Treatment with venlafaxine extended release after SSRI non-response or intolerance: A randomized comparison of standard- and higher-dosing strategies. J Clin Psychopharmacol 26:250-258, 2003
35. Vincent A, Barton DL, Mandrekar JN, et al: Acupuncture for hot flashes: A randomized, shamcontrolled, clinical study. Menopause 14:45-52, 2007
36. Tremblay A, Sheeran L, Aranda SK: Psychoeducational interventions to alleviate hot flashes: A systematic review. Menopause 10.1097/gme. 0b013e31805c08dc [epub ahead of print on June 21, 2007]
37. Berglund G, Nystedt M, Bolund C, et al: Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: A prospective randomized study. J Clin Oncol 19:2788-2796, 2001
38. Malinovszky K, Gould A, Foster E, et al: Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer 95:1626-1631, 2006
39. Land SR, Wickerham DL, Costantino JP, et al: Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2742-2751, 2006
40. Day R: National Surgical Adjuvant Breast and Bowel Project P-1 study (NSABP-1): Quality of life and tamoxifen in a breast cancer prevention trial: A summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project. Ann N Y Acad Sci 949:143-150, 2001
41. Fobair P, Stewart SL, Chang S, et al: Body image and sexual problems in young women with breast cancer. Psychooncology 15:579-594, 2006
42. Beckjord E, Campas BE: Sexual quality of life in women with newly diagnosed breast cancer. J Psychosocial Oncol 25:19-36, 2007
43. Taylor KL, Lamdan RM, Siegel JE, et al: Treatment regimen, sexual attractiveness concerns and psychological adjustment among African American breast cancer patients. Psychooncology 11:505-517, 2002
44. Takahashi M, Kai I: Sexuality after breast cancer treatment: Changes and coping strategies among Japanese survivors. Soc Sci Med 61:1278-1290, 2005
45. Wimberly SR, Carver CS, Laurenceau JP, et al: Perceived partner reactions to diagnosis and treatment of breast cancer: Impact on psychosocial and psychosexual adjustment. J Consult Clin Psychol 73:300-311, 2005
46. Speer JJ, Hillenberg B, Sugrue DP, et al: Study of sexual functioning determinants in breast cancer survivors. Breast J 11:440-447, 2005
47. Andersen BL, Carpenter KM, Yang HC, et al: Sexual well-being among partnered women with breast cancer recurrence. J Clin Oncol 25:3151-3157, 2007
48. Laumann EO, Paik A, Rosen RC: Sexual dysfunction in the United States: Prevalence and predictors. JAMA 281:537-544, 1999
49. Wyatt GE, Loeb TB, Desmond KA, et al: Does a history of childhood sexual abuse affect sexual outcomes in cancer survivors? J Clin Oncol 23:1261-1269, 2005
50. Schover LR, Jenkins R, Sui D, et al: Randomized trial of peer counseling on reproductive health in African American breast cancer survivors. J Clin Oncol 24:1620-1626, 2006
51. Greendale GA, Peterson L, Zibecchi L, et al: Factors related to sexual function in postmenopausal women with a history of breast cancer. Menopause 8:111-119, 2001
52. Barton DL, Wender DB, Sloan JA, et al: Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group Protocol NO2C3. J Natl Cancer Inst 99:672-679, 2007
53. Ganz PA, Greendale GA: Editorial: Female sexual desire - beyond testosterone. J Natl Cancer Inst 99:659-661, 2007
54. Schover LR: Androgen therapy for loss of desire in women: Is the benefit worth the breast cancer risk? Fertil Steril [epub ahead of print on November 17, 2007]
55. Loprinzi CL, Abu-Ghazaleh S, Sloan JA, et al: Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 15:969-973,1997
56. Schover LR: Sexuality and Fertility After Cancer. New York, NY, John Wiley & Sons, 1997
57. Ganz PA, Greendale GA, Petersen L, et al: Managing menopausal symptoms in breast cancer survivors: Results of a randomized controlled trial. J Natl Cancer Inst 92:1054-1064, 2000
58. Kalaitzi C, Papadopoulos VP, Michas K, et al: Combined brief psychosexual intervention after mastectomy: Effects on sexuality, body image, and psychologic well-being. J Surg Oncol 96:235-240, 2007
59. Shadiack AM, Sharma SD, Earle DC, et al: Melanocortins in the treatment of male and female sexual dysfunction. Current Top Medicinal Chem 7:1137-1144, 2007
60. Weisberg E, Ayton R, Darling G, et al: Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 8:83-92, 2005
61. Kendall A, Dowsett M, Folkerd E, et al: Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 17:584-587, 2006
62. North American Menopause Society: The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause 14:355-369, 2007
63. Lee SJ, Schover LR, Partridge A, et al: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917-2931, 2006
64. Azim AA, Costantini-Ferrando M, Lostritto K, et al: Relative potencies of anastrozole and letrozole to suppress estradiol in cancer patients undergoing ovarian stimulation before in vitro fertilization. J Clin Endocrinol Metab 92:2197-2200, 2007
65. The Practice Committee of the American Society for Reproductive Medicine and Practice Committee of the Society for Assisted Reproductive Technology: Ovarian tissue and oocyte cryopreservation. Fertil Steril 86:S142-S147, 2006 (5 suppl)
66. Oktay K, Cil AP, Bang H: Efficiency of oocyte cryopreservation: A meta-analysis. Fertil Steril 86:70-80, 2006
67. Oktay K, Demirtas F, Son WY et al: In vitro maturation of germinal vesicle oocytes recovered after premature luteinizing hormone surge: Description of a novel approach to fertility preservation. Fertil Steril 10.1016/j.fertnstert.2007.02.028 [epub ahead of print on May 19, 2007]
68. Adjuvant Breast Cancer Trials Collaborative Group: Ovarian ablation or suppression in premenopausal early breast cancer: Results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial. J Natl Cancer Inst 99:516-525, 2007
69. Ives A, Saunders C, Bulsara M, et al: Pregnancy after breast cancer: Population based study. BMJ 334:194, 2007